drugset / Trial / NCT01355991
Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI
Phase 1
Unknown
40 enrolled
James J. Peters Veterans Affairs Medical Center
Kessler Institute for Rehabilitation · collab
RandomizedCrossoverOpen-labelTreatment
Summary
To determine the acute and chronic effects of a short course of treatment on spinal cord injured (SCI) individuals with either an anticholinergic agent (tiotropium) or with a β₂ agonist (Salmeterol) on: * Fraction of expired NO (FeNO) * Selected Biomarkers of inflammation in exhaled breath condensates (EBC) * Pulmonary function, as measured by pulmonary function tests and body plethysmography
Timeline
- Start
- 2011-08
- Primary completion
- 2016-03
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Salmeterol | Other / unclassified | 50 ug | Inhaled |
| Comparator | Tiotropium | Other / unclassified | 18 ug | Inhaled |